Drug Detail

Information about KQB198

Generic Name
IND	KQB198
Brand Name (US)
Manufacturer	Kumquat Biosciences
Drug Type
Delivery	Oral
Approval Status
Indications
Overall Strategy	KIT Protein Based + Oncogenic Signal Path Based
Strategy	Block KIT + Block KIT Signal Path
Drug Category	RAS Pathway inhibitor

Links
Trials of this drug
	KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)

Trial results